BIOS Option Care Health Inc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc.

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces it has commenced an investigation of BioScrip, Inc. (NASDAQGM:BIOS) concerning possible violations of federal securities laws. On March 8, 2018, BioScrip released its preliminary fourth quarter and full year financial results and disclosed that the Company had begun an internal accounting review after identifying “internal control deficiencies in connection with account reconciliations for certain asset and liability accounts.” The Company also announced that it “has identified and will report a material weakness related to certain spreadsheets used to calculate periodic adjustments to” certain accounts. Upon this news, shares of BioScrip were down more than 15% on intraday trading on March 8, 2018. To obtain additional information, go to:

http://www.zlkdocs.com/BIOS-Info-Request-Form-6517

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
08/03/2018

Underlying

BIOSOption Care Health Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Option Care Health Inc

 PRESS RELEASE
Free
BIOS Option Care Hea...

Option Care Health to Announce Third Quarter 2019 Financial Results an...

Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call BANNOCKBURN, Ill., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the Company will release results for its third quarter ended September 30, 2019 on Wednesday, November 6, 2019 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details ...

October 16, 2019 1 EN
 PRESS RELEASE
Free
BIOS Option Care Hea...

BioScrip Announces Shareholder Approval of Merger with Option Care

BioScrip Announces Shareholder Approval of Merger with Option Care DENVER, Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the “Company”), the largest independent national provider of infusion and home care management solutions, today announced that its stockholders approved the proposals that are conditions to the proposed merger with Option Care at the Company’s special meeting of stockholders held earlier today.  BioScrip’s merger with Option Care is expected to close on or about August 6, 2019. About BioScrip, Inc. BioScrip, Inc. is the largest ...

August 2, 2019 1 EN
 PRESS RELEASE
Free
BIOS Option Care Hea...

BioScrip Reports Second Quarter 2019 Financial Results

BioScrip Reports Second Quarter 2019 Financial Results DENVER, July 30, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2019 financial results. Second Quarter 2019 BioScrip Highlights Net revenue of $191.5 million, up 8.9% compared to $175.8 million in the second quarter of 2018.Gross revenue1 of $196.8 million, up 13.1% compared to $174.0 million in the prior year quarter.Net loss from continuing operations of $14.2 million, ...

July 30, 2019 1 EN
 PRESS RELEASE
Free
BIOS Option Care Hea...

Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recomme...

Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care DENVER, July 22, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”), leading independent proxy advisory firms, recommend that BioScrip stockholders vote “FOR” the proposals that are cond...

July 22, 2019 1 EN
Free Trial
BIOS Option Care Hea...

Increased risk weighs on BIOSCRIP INCO., penalising its rating down t...

The independent financial analyst theScreener just lowered the general evaluation of BIOSCRIP INCO. (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date June 14, 2019, the clos...

BIOS OPTION CARE HEALTH INC
06/15/19 June 15, 2019 6 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch